Committee 2012
Committee:
Steering Committee Chair:
Johannes Mosbacher | Actelion Pharmaceuticals, Allschwil, CH |
Steering Committee Members:
Bhupinder Bhullar | Novartis Pharma AG, Basel, CH (Program Committee Chair) |
Christof Fattinger | F. Hoffman-La Roche Ltd., Basel, CH (Program Committee Chair) |
Sabine Adam | Congrex Switzerland Ltd., Basel, CH |
Doris Hafenbradl | BioFocus, Allschwil, CH |
Vanessa King | deCode Genetics, Reykavik, IS |
Roland Bucher | Bucher Biotec, Basel, CH (Representative of the Exhibitors) |
Program Committee:
Drug Discovery Technologies
Gregor Dernick | F. Hoffmann-La Roche Ltd, Basel, CH |
Martin Valler | Boehringer Ingelheim Pharma GmbH&Co.KG, Biberach, DE |
Biology Space
Emilio Diez | GlaxoSmithKline S.A, Madrid, ES |
Sabrina Corazza | Axxam, Milan, IT |
Chemistry Space
Chris Lipinski | Melior Discovery, Waterford, US |
John Harris | cjh consultants, Eynsford, UK |
Structural and Computational Drug Discovery
Michael Sundström | Karolinska Development AB, Solna, SE |
Alexander Hillisch | Bayer Healthcare Pharma, Wuppertal, DE |
Customized Therapies
Michael Rotte | Novartis Pharma AG, Basel, CH |
Andreas Schneider | Roche Diagnostics AG, Rotkreuz, CH |
Early Toxicology Evaluation
Claudia Mc Ginnis | F. Hoffmann-La Roche Ltd., Basel, CH |
Jacques Hamon | Novartis Pharma AG, Basel, CH |
Biopharmaceuticals
Arne Skerra | Technical University Munich, Freising-Weihenstephan, DE |
Stefan Dübel | Technical University Braunschweig, Braunschweig, DE |
High Content Screening
Enrico Schmidt | Novartis Pharma AG, Basel, CH |
Neil Carragher | Edinburgh Cancer Research Centre, Edinburgh, UK |
Next Generation Sequencing Scientific Session
Christopher Mason | Weill-Cornell Medical College, New York, US |
Niels Kruize | LGC Genomics, Utrecht, NL |
Synthetic Biology
Yaakov Benenson | ETH Zurich, Basel, CH |
Bhupinder Bhullar | Novartis Pharma AG, Basel, CH |
Coordination User Group Meetings:
Nathalie Joly | Cisbio Bioassays, Codolet, FR |
Doris Hafenbradl | BioFocus, Allschwil, CH |